Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: Night Trader who wrote (625)	2/12/1999 9:08:00 AM
From: steven Probst	Read Replies (1) \| Respond to of 696

To All: SEC filing 2/11/99: SC 13G, Dimensional Fund Advisors and/or its clients own 548,400 shares or 7.64%. Regards, steve

To: Night Trader who wrote (625)	2/12/1999 9:25:00 AM
From: Joe Dancy	Respond to of 696

Thanks Martin. I really don't buy off on Murphy's "growth flow" theory, and had not run the numbers here, but they obviously look interesting. I like your analysis - do you think that the ratio is where it is at due to "inefficiencies of being such a small company" when compared to TECH? Or due to aggressive product development? I've talked to some in the industry that use BIOI products by e-mail, and they like the products and they like the company - and that is really all I need to know, but obviously it is not an indication of future growth. Some of the analysts who cover the company (the ones who are paid :)) think that the product stream is strong, or at least will sustain growth in the teens, which is what management also believes. Thanks for crunching the numbers. Joe